Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors

Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiologia Croatica 2016-07, Vol.11 (8), p.330-342
Hauptverfasser: Matijevic Roncevic, Sanja, Gobic, David, Zaninovic Jurjevic, Teodora, Rubesa Miculinic, Zeljka, Zaputovic, Luka
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 342
container_issue 8
container_start_page 330
container_title Cardiologia Croatica
container_volume 11
creator Matijevic Roncevic, Sanja
Gobic, David
Zaninovic Jurjevic, Teodora
Rubesa Miculinic, Zeljka
Zaputovic, Luka
description
doi_str_mv 10.15836/ccar2016.330
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_15836_ccar2016_330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_15836_ccar2016_330</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_15836_ccar2016_3303</originalsourceid><addsrcrecordid>eNqVjsGKwjAURYOMoIwu3ecH6iSmKXVdFYfpQtSFu5C2qQ3URN6Lin-vI-re1b1wz4VDyIizMZepSH7KUsOE8WQsBOuQPk_jNJJxnH69u9j1yBDRFmySyKmUMumT9cyirs7aBb03SH1NsxOAcYHmszwqG98aDAZ8S3N_MWDdnmpX0dAYur5v_4dVtvmb0l_X2MIGDzgg3Vq3aIbP_CbRYr7NllEJHhFMrY5gDxquijP1cFcvd3V3F5_yN4m9S_U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors</title><source>Alma/SFX Local Collection</source><creator>Matijevic Roncevic, Sanja ; Gobic, David ; Zaninovic Jurjevic, Teodora ; Rubesa Miculinic, Zeljka ; Zaputovic, Luka</creator><creatorcontrib>Matijevic Roncevic, Sanja ; Gobic, David ; Zaninovic Jurjevic, Teodora ; Rubesa Miculinic, Zeljka ; Zaputovic, Luka</creatorcontrib><identifier>ISSN: 1848-543X</identifier><identifier>EISSN: 1848-5448</identifier><identifier>DOI: 10.15836/ccar2016.330</identifier><language>eng</language><ispartof>Cardiologia Croatica, 2016-07, Vol.11 (8), p.330-342</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-1880-1493 ; 0000-0001-9415-9618 ; 0000-0003-0627-2114 ; 0000-0001-8359-3910 ; 0000-0001-9406-1127</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Matijevic Roncevic, Sanja</creatorcontrib><creatorcontrib>Gobic, David</creatorcontrib><creatorcontrib>Zaninovic Jurjevic, Teodora</creatorcontrib><creatorcontrib>Rubesa Miculinic, Zeljka</creatorcontrib><creatorcontrib>Zaputovic, Luka</creatorcontrib><title>Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors</title><title>Cardiologia Croatica</title><issn>1848-543X</issn><issn>1848-5448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqVjsGKwjAURYOMoIwu3ecH6iSmKXVdFYfpQtSFu5C2qQ3URN6Lin-vI-re1b1wz4VDyIizMZepSH7KUsOE8WQsBOuQPk_jNJJxnH69u9j1yBDRFmySyKmUMumT9cyirs7aBb03SH1NsxOAcYHmszwqG98aDAZ8S3N_MWDdnmpX0dAYur5v_4dVtvmb0l_X2MIGDzgg3Vq3aIbP_CbRYr7NllEJHhFMrY5gDxquijP1cFcvd3V3F5_yN4m9S_U</recordid><startdate>20160710</startdate><enddate>20160710</enddate><creator>Matijevic Roncevic, Sanja</creator><creator>Gobic, David</creator><creator>Zaninovic Jurjevic, Teodora</creator><creator>Rubesa Miculinic, Zeljka</creator><creator>Zaputovic, Luka</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-1880-1493</orcidid><orcidid>https://orcid.org/0000-0001-9415-9618</orcidid><orcidid>https://orcid.org/0000-0003-0627-2114</orcidid><orcidid>https://orcid.org/0000-0001-8359-3910</orcidid><orcidid>https://orcid.org/0000-0001-9406-1127</orcidid></search><sort><creationdate>20160710</creationdate><title>Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors</title><author>Matijevic Roncevic, Sanja ; Gobic, David ; Zaninovic Jurjevic, Teodora ; Rubesa Miculinic, Zeljka ; Zaputovic, Luka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_15836_ccar2016_3303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Matijevic Roncevic, Sanja</creatorcontrib><creatorcontrib>Gobic, David</creatorcontrib><creatorcontrib>Zaninovic Jurjevic, Teodora</creatorcontrib><creatorcontrib>Rubesa Miculinic, Zeljka</creatorcontrib><creatorcontrib>Zaputovic, Luka</creatorcontrib><collection>CrossRef</collection><jtitle>Cardiologia Croatica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matijevic Roncevic, Sanja</au><au>Gobic, David</au><au>Zaninovic Jurjevic, Teodora</au><au>Rubesa Miculinic, Zeljka</au><au>Zaputovic, Luka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors</atitle><jtitle>Cardiologia Croatica</jtitle><date>2016-07-10</date><risdate>2016</risdate><volume>11</volume><issue>8</issue><spage>330</spage><epage>342</epage><pages>330-342</pages><issn>1848-543X</issn><eissn>1848-5448</eissn><doi>10.15836/ccar2016.330</doi><orcidid>https://orcid.org/0000-0002-1880-1493</orcidid><orcidid>https://orcid.org/0000-0001-9415-9618</orcidid><orcidid>https://orcid.org/0000-0003-0627-2114</orcidid><orcidid>https://orcid.org/0000-0001-8359-3910</orcidid><orcidid>https://orcid.org/0000-0001-9406-1127</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1848-543X
ispartof Cardiologia Croatica, 2016-07, Vol.11 (8), p.330-342
issn 1848-543X
1848-5448
language eng
recordid cdi_crossref_primary_10_15836_ccar2016_330
source Alma/SFX Local Collection
title Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T17%3A40%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disadvantages%20of%20Current%20LDL-cholesterol%20Lowering%20and%20the%20Role%20of%20PCSK9%20Inhibitors&rft.jtitle=Cardiologia%20Croatica&rft.au=Matijevic%20Roncevic,%20Sanja&rft.date=2016-07-10&rft.volume=11&rft.issue=8&rft.spage=330&rft.epage=342&rft.pages=330-342&rft.issn=1848-543X&rft.eissn=1848-5448&rft_id=info:doi/10.15836/ccar2016.330&rft_dat=%3Ccrossref%3E10_15836_ccar2016_330%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true